The safety and efficacy of SGLT2 inhibitors

SLGT2 Inhibitors

Since the SGLT-2 inhibitors have been launched there have been studies that have suggested potential concerns such as ketoacidosis and amputation and those that have demonstrated positive benefits on cardiovascular outcomes. This meta-analysis of the drugs may dispel the anxieties that some primary care clinicians have had over prescribing them.

http://jaha.ahajournals.org/content/7/2/e007165

Share

Related Articles

6th January 2014

Trial behind closed doors?

“An MP’s Committee has warned that drugs companies routinely withhold results of clinical trials from doctors,...

Read More

9th May 2014

The cost of Diabetes

It’s been a week for bad news in Healthcare.  As well as the bad news about asthma mortality, are other items...

Read More

17th February 2012

The Price Is Right?

A pressure to reduce overall drug costs had to come as part of the government drive to reduce overall spending.  It is...

Read More